A chalazion is a common eyelid condition that is usually benign and often settles with simple treatment. However, persistent, recurrent or atypical eyelid lumps may benefit from specialist assessment.
For primary care clinicians and other healthcare professionals, recognising when a chalazion is no longer following the expected course can help ensure appropriate and timely referral.
What is a chalazion?
A chalazion is a localised inflammatory lesion caused by blockage of one of the eyelid’s meibomian glands. These glands produce an oily component of the tear film that helps prevent excessive evaporation of tears.
When a meibomian gland becomes obstructed, its contents can accumulate within the eyelid, triggering a localised inflammatory response. A chalazion is therefore not usually an infection, although it may develop following an internal hordeolum (stye) or in association with underlying meibomian gland dysfunction.
Patients typically notice a firm, localised lump within the eyelid. Larger lesions can sometimes cause tenderness, swelling or pressure on the eye and, if they become sufficiently prominent, may contribute to temporary visual disturbance.
Initial management of a chalazion
Most chalazia can initially be managed conservatively. Warm compresses and good lid hygiene remain the mainstays of first-line treatment.
Patients can generally be advised to apply a comfortably warm compress to the closed eyelid regularly, followed by gentle eyelid cleansing. Consistent treatment may help improve meibomian gland function and encourage resolution of the blockage.
The clinical course can vary, and resolution is not always immediate. It is therefore important to consider the duration of the lesion, the patient’s symptoms and whether there are any contributing eyelid conditions.
Why do some chalazia keep coming back?
Recurrent chalazia may indicate an underlying problem affecting the eyelid margins or meibomian glands. Relevant factors can include:
- Meibomian gland dysfunction (MGD)
- Chronic blepharitis
- Rosacea and associated eyelid inflammation
- Recurrent obstruction of the meibomian glands
Addressing these underlying factors can be important in patients who experience repeated episodes. A history of recurrent eyelid lumps may therefore warrant a broader assessment of ocular surface and eyelid health rather than simply treating each lesion in isolation.
When should a chalazion be referred?
Most chalazia do not require specialist intervention. However, referral for an oculoplastic assessment should be considered when a lesion:
- Persists for more than approximately 4–6 weeks despite appropriate conservative treatment
- Is large or causes significant discomfort or visual disturbance
- Recurs frequently
- Repeatedly develops in the same location
- Has an atypical appearance or clinical course
- Raises diagnostic uncertainty
The 4–6 week timeframe is a useful practical guide rather than an absolute rule. Earlier assessment may be appropriate when symptoms are significant, the lesion is particularly large, or there are features that do not fit the expected presentation of a straightforward chalazion.
Why is assessment of recurrent or atypical lesions important?
Although the overwhelming majority of eyelid lumps are benign, a persistent or recurrent lesion should not automatically be assumed to be a chalazion.
Particular attention should be paid to lesions that recur in the same location or demonstrate unusual clinical features. In selected cases, further investigation may be appropriate to exclude less common eyelid pathology.
Histopathological examination is not routinely required for every chalazion. Where the clinical presentation warrants further investigation, however, tissue obtained during treatment may be submitted for histopathological analysis.
What can specialist treatment involve?
Where conservative treatment has failed, an oculoplastic specialist can assess whether definitive intervention is appropriate.
For a suitable persistent chalazion, incision and curettage may provide definitive treatment by opening the lesion and removing its contents. The most appropriate approach depends on the individual patient, the characteristics of the lesion and the clinical diagnosis.
Specialist management can also provide an opportunity to assess the wider eyelid and identify contributing conditions such as meibomian gland dysfunction or chronic blepharitis.
A practical approach for clinicians
When reviewing a patient with a persistent eyelid lump, it can be helpful to consider:
1. Is the clinical diagnosis consistent with a chalazion?
Consider the appearance, duration, symptoms and location of the lesion.
2. Has appropriate conservative treatment been tried?
Warm compresses and lid hygiene remain the usual first-line measures.
3. Is there an underlying eyelid disorder?
Recurrent lesions should prompt consideration of meibomian gland dysfunction, blepharitis or rosacea.
4. Is the lesion persistent or recurrent?
A lesion that remains despite several weeks of appropriate treatment may benefit from specialist review.
5. Are there atypical features?
An unusual appearance, repeated recurrence in the same location or diagnostic uncertainty should lower the threshold for referral.
For patients: when should you seek advice?
Most eyelid lumps are not serious and will improve with appropriate treatment. However, you should seek medical advice if an eyelid lump does not settle, repeatedly returns, becomes increasingly troublesome or affects your vision.
A persistent eyelid lump should not simply be assumed to be another stye or chalazion, particularly if it behaves differently from previous episodes.
Summary
Chalazia are common and usually benign, with warm compresses and eyelid hygiene forming the foundation of initial management. For patients with persistent or recurrent lesions, however, specialist assessment can help establish the diagnosis, identify underlying eyelid disease and determine whether definitive treatment is appropriate.
For colleagues managing patients with eyelid lesions, a 4–6 week period of persistence despite appropriate conservative treatment is a useful point at which to consider oculoplastic referral, while atypical or recurrent lesions may warrant earlier assessment.
This article is intended for general educational purposes and does not replace an individual clinical assessment. Referral decisions should be based on the patient’s presentation, clinical findings and professional judgement.
Arrange a consultation with Mr Hugo Henderson; contact his secretary at: secretary@hugohenderson.com